SETH V HETHERINGTON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SETH V HETHERINGTON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SETH V HETHERINGTON. SETH V HETHERINGTON is VP, Clinical Development & CMO in INHIBITEX, INC. ($INHX) and Chief Medical Officer in GENOCEA BIOSCIENCES, INC. ($GNCA).
Latest Insider Trading Transactions of SETH V HETHERINGTON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2017 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | A | 4.67 | 100,000 | 467,000 | 100,000 | |
| Nov 09 2016 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | M | 2.02 | 5,000 | 10,100 | 61,955 | |
| Nov 09 2016 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Buy | M | 2.02 | 5,000 | 10,100 | 26,000 | 21 K to 26 K (+23.81 %) |
| Feb 04 2016 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | A | 3.09 | 100,000 | 309,000 | 100,000 | |
| Dec 15 2015 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | M | 2.02 | 5,000 | 10,100 | 66,955 | |
| Dec 15 2015 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Buy | M | 2.02 | 5,000 | 10,100 | 21,000 | 16 K to 21 K (+31.25 %) |
| Aug 11 2015 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | M | 2.02 | 2,011 | 4,062 | 71,955 | |
| Aug 11 2015 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | M | 2.02 | 2,989 | 6,038 | 11,562 | |
| Aug 11 2015 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Buy | M | 2.02 | 2,011 | 4,062 | 16,000 | 14 K to 16 K (+14.38 %) |
| Aug 11 2015 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Buy | M | 2.02 | 2,989 | 6,038 | 13,989 | 11 K to 14 K (+27.17 %) |
| Mar 02 2015 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | A | 9.08 | 51,000 | 463,080 | 51,000 | |
| Dec 13 2005 | INHX | INHIBITEX, INC. | HETHERINGTON SETH V | VP, Clinical Develo ... | Option Exercise | X | 1.90 | 2,195 | 4,171 | 73,436 | |
| Dec 13 2005 | INHX | INHIBITEX, INC. | HETHERINGTON SETH V | VP, Clinical Develo ... | Sell | D | 9.00 | 2,195 | 19,755 | 0 | 2.2 K to 0 (-100.00 %) |
| Feb 22 2005 | INHX | INHIBITEX, INC. | HETHERINGTON SETH V | VP, Clinical Develo ... | Option Exercise | A | 9.07 | 50,000 | 453,500 | 50,000 |
Page: 1